San Diego-based Viking Therapeutics marked alone as a significant competitor from the weight loss drug market in February immediately after revealing promising info from a mid-stage trial of experimental drug VK2735, which advised it rivaled—and outperformed—Novo and Lilly drugs when offered like a weekly injection As well as in March the compa